Literature DB >> 15626880

Common grounds for erectile dysfunction and coronary artery disease.

Piero Montorsi1, Paolo M Ravagnani, Stefano Galli, Francesco Rotatori, Alberto Briganti, Andrea Salonia, Federico Dehò, Francesco Montorsi.   

Abstract

PURPOSE OF REVIEW: Evidence is accumulating to consider erectile dysfunction as a vascular problem. This review focuses on background, pathophysiological mechanisms and clinical evidence of the link between erectile dysfunction and coronary artery disease. RECENT
FINDINGS: The link between erectile dysfunction and coronary artery disease is suggested by the following. (1) Common risk factors for atherosclerosis are frequently found in erectile dysfunction. (2) Erectile dysfunction is frequently found in vascular syndromes such as coronary artery disease, hypertension, cerebrovascular disease, peripheral arterial disease and diabetes. (3) A similar pathogenic involvement of the NO pathway leading to impairment of endothelium-dependent vasodilatation and late structural vascular abnormalities is shared by erectile dysfunction and vascular disorders. Given this background, the "artery-size hypothesis" is a recently proposed pathophysiological mechanism to explain the link between sexual dysfunction and myocardial ischemia.
SUMMARY: Erectile dysfunction and coronary artery disease appear to be linked tightly each other.

Entities:  

Mesh:

Year:  2004        PMID: 15626880     DOI: 10.1097/00042307-200411000-00012

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  19 in total

Review 1.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

2.  Erectile dysfunction and coronary artery calcification in incident dialysis patients.

Authors:  Neil Roy; Sylvia Eleni Rosas
Journal:  J Nephrol       Date:  2021-03-08       Impact factor: 3.902

3.  Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?

Authors:  Andre B Araujo; Susan A Hall; Peter Ganz; Gretchen R Chiu; Raymond C Rosen; Varant Kupelian; Thomas G Travison; John B McKinlay
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

Review 4.  Erectile Dysfunction and Ischaemic Heart Disease.

Authors:  Abdalla Ibrahim; Mohamed Ali; Thomas J Kiernan; Austin G Stack
Journal:  Eur Cardiol       Date:  2018-12

5.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

6.  Erectile dysfunction and mortality.

Authors:  Andre B Araujo; Thomas G Travison; Peter Ganz; Gretchen R Chiu; Varant Kupelian; Raymond C Rosen; Susan A Hall; John B McKinlay
Journal:  J Sex Med       Date:  2009-06-15       Impact factor: 3.802

7.  NS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels, enhances erectile responses in rats.

Authors:  A Kun; V V Matchkov; E Stankevicius; A Nardi; A D Hughes; H J Kirkeby; J Demnitz; U Simonsen
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

8.  Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severity.

Authors:  Onder Yaman; Omer Gulpinar; Taner Hasan; Cagdas Ozdol; Fatih S Ertas; Enver Ozgenci
Journal:  Int Urol Nephrol       Date:  2007-11-02       Impact factor: 2.370

Review 9.  Metabolic syndrome and risk for ED: a meta-analysis.

Authors:  L H Liu; T Zhang; Y R Zhang; T S Liu; H B Zhang; F Z Chen; S H He; A Y Wei
Journal:  Int J Impot Res       Date:  2014-03-06       Impact factor: 2.896

Review 10.  Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.

Authors:  Dimitrios Terentes-Printzios; Nikolaos Ioakeimidis; Konstantinos Rokkas; Charalambos Vlachopoulos
Journal:  Nat Rev Cardiol       Date:  2021-07-30       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.